Compare gera Therapeutics vs Regado Biosciences
Customers evaluate the quality of gera Therapeutics's products using the following success metrics.
Overview
gera Therapeutics is 24 yrs old and is based in Canada.
Aegera Therapeutics, located in Montreal, Canada, is a business unit of Pharmascience focused on developing targeted therapeutics to address major unmet medical needs. Aegera focuses on preclinical and early-stage clinical development through integration of "in-house" medicinal chemistry, biochemistry, cell biology, pharmacokinetics and in vivo pharmacology/efficacy. Aegera has two oncology programs in clinical development. Aegera is also dedicated to identifying novel development candidates based upon its core technologies, internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.
Regado Biosciences is 21 yrs old and is based in United States.
Regado Biosciences, a biopharmaceutical company, engages in the discovery and development of aptamer-based antidote-controlled therapeutics. The Company provides REG1 that is used in patients suffering from acute coronary syndrome that undergo coronary revascularization procedures, which include coronary artery bypass grafting and percutaneous coronary intervention.
Demo Video
Leadership
Michael J Berendt (Chief Executive Officer, President)
Doug Gooding (Founder)
Investors
Pharmascience, GrowthWorks
Aurora Funds, Domain Associates
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because gera Therapeutics has not claimed their profile.
Work for gera Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for gera Therapeutics?
Claim your profile now.
Information not available because Regado Biosciences has not claimed their profile.
Work for Regado Biosciences? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Regado Biosciences?
Claim your profile now.